NDAINJECTIONINJECTABLE
Approved
Dec 1988
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
OPTIRAY 240 (ioversol) by Guerbet is x-ray contrast activity [moa]. First approved in 1988.
Drug data last refreshed 5h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
OPTIRAY 240 (ioversol) is an injectable radiographic contrast agent used to enhance visibility of internal body structures during X-ray and imaging procedures. It works through X-ray contrast activity, enabling radiologists to visualize vasculature, organs, and tissues with improved clarity. Ioversol is a non-ionic, low-osmolality contrast medium administered intravenously for diagnostic imaging.
LOE Approaching
Product is approaching loss of exclusivity with moderate competitive pressure (30/100), indicating potential team restructuring and transition planning in coming years.
Mechanism of Action
X-Ray Contrast Activity
Pharmacologic Class:
Radiographic Contrast Agent
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on OPTIRAY 240 offers limited growth trajectory due to LOE approaching status and zero linked job openings. Career development on this product is best suited for professionals seeking stability in a mature franchise rather than rapid advancement or team expansion.
Brand ManagerField Sales Representative
Worked on OPTIRAY 240 at Guerbet? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.